Cellular translational machinery (null)

The cellular translational machinery is the collective term for the molecular system responsible for synthesizing proteins from messenger RNA (mRNA) templates. It primarily consists of ribosomes, numerous translation factors (incl. eIFs, EFs), transfer RNAs (tRNAs), and associated enzymes[1][3][6][7]. In eukaryotes, translation begins when the small ribosomal subunit binds mRNA, is guided by initiation factors, and scans for a start codon[1]. Elongation involves tRNA delivery of amino acids and catalytic peptide bond formation, mediated by the ribosome's peptidyl transferase activity[4][6]. Termination is triggered by release factors recognizing stop codons, enabling release of the newly formed polypeptide[4][6]. The machinery is highly regulated, exhibits cell-type and compartment-specific specialization, and its dysfunction is implicated in a wide range of diseases—including cancer, neurodegeneration, and infection[2][3][5][7]. Drugs targeting its core components are used as antibiotics or anticancer agents but face challenges in specificity and safety due to its essential role in normal cellular physiology[3][6].

Other names

protein synthesis machinerytranslation apparatustranslation complexprotein translation system

Inhibition of ribosome function (prevents peptide synthesis) - Interference with translation initiation complex formation - Disruption of elongation and translocation steps[1][3][6] - Modulation of translation factor activity (signaling pathways such as mTOR)